A reproductive screening test of hawthorn

Journal of Ethnopharmacology

Volumn 118, Issue 1, 2008, Pages 127-132

  Yao, Mei ^a   Ritchie, Helen E ^a   Brown Woodman, Patricia D ^a  

^a University of Sydney   (Australia)

Author keywords

Complementary medicine; Developmental toxicology; Embryo culture; Hawthorn; Pregnancy; Rat; Teratology

Indexed keywords

CRATAEGUS EXTRACT;

ALTERNATIVE MEDICINE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRATAEGUS; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG TOLERABILITY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS WEIGHT; GESTATION PERIOD; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PREGNANCY; RAT; REPRODUCTIVE TOXICITY; SCREENING TEST; SKELETON MALFORMATION; TERATOLOGY;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CRATAEGUS; EMBRYO, MAMMALIAN; FEMALE; GESTATIONAL AGE; HUMANS; MALE; PLANT EXTRACTS; PREGNANCY; PREGNANCY OUTCOME; RATS; REPRODUCTION; TIME FACTORS; TOXICITY TESTS;

CRATAEGUS; RATTUS;

EID: 44149106104     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.03.020     Document Type: Article

References (29)

1. Barrow M.V., and Taylor W.J. A rapid method for detecting malformations in rat fetuses. Journal of Morphology 127 (1969) 291-305
2. Brown J.P., and Dietrich P.S. Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutation Research 66 (1979) 223-240
3. Brown N., and Fabro S. Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology 24 (1981) 65-78
4. Chang Q., Zuo Z., Ho W., and Chow M. Comparison of the pharmacokinetics of hawthorn phenolics in extract versus individual pure compound. Journal of Clinical Pharmacology 45 (2005) 106-112
5. Chen X., Yin O., Zuo Z., and Chow M. Pharmacokinetics and modeling of quercetin and metabolites. Pharmaceutical Research 22 (2005) 892-901
6. Daniele C., Mazzanti G., Pittler M.H., and Ernst E. Adverse-event profile of Crataegus spp. A systematic review. Drug Safety 29 (2006) 523-535
7. David W.B., and Kristina U. Extensive binding of the bioflavonoid quercetin to human plasma proteins. The Journal of Pharmacy and Pharmacology 50 (1998) 243-249
8. Ejiri N., Katayama K., Kiyosawa N., Baba Y., and Doi K. Microarray analysis on CYPs expression in pregnant rats after treatment with pregnenolone-16alpha-carbonitrile and phenobarbital. Experimental & Molecular Pathology 78 (2005) 71-77
9. Elliott Milddleton J.R., and Kandaswami C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacological Reviews 52 (2000) 673-751
10. Gu L., House S., and Prior R. Effects of level of dietary sorghum procyanidins on early growth and development of rats. FASEB Journal 20 (2006) A154
11. HerbalGram. Hawthorn. (1990) 20-33
12. Hollman P.C., de Vries J.H., van Leeuwen S.D., Mengelers M.J., and Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. The American Journal of Clinical Nutrition 62 (1995) 1276-1282
13. Hou J.P. The Development of Chinese Herbal Medicine and the Pen-Ts'ai. Comparative Medicine East and West 5 (1977) 117-122
14. Hsu H.Y. Oriental Materia Medica (1986), Oriental Healing Arts Institute, Long Beach
15. Maats F., and Crowther C. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Australian & New Zealand Journal of Obstetrics & Gynaecology 42 (2002) 494-496
16. MacLennan A., Wilson D., and Taylor A. Prevalence and cost of alternative medicine in Australia. Lancet 347 (1996) 569-573
17. Nagao M., Morita N., Yahagi T., Shimizu M., Kuroyanagi M., Fukuoka M., Yoshihira K., Natori S., Fujino T., and Sugimura T. Mutagenicities of 61 flavonoids and 11 related compounds. Environmental Mutagenesis 3 (1981) 401-419
18. New D.A. Studies on mammalian fetuses in vitro during the period of organogenesis. In: Austin C.R. (Ed). The Mammalian Fetus In Vitro (1973), Chapman and Hall, London 15-65
19. Newall C.A. Herbal Medicines: A Guide for Health-care Professionals (1996), Pharmaceutical Press, London
20. NTP, 1999. Toxicology and carcinogenesis studies of quercetin (CAS NO. 117-39-5) in F344/N rats (feed studies). National Toxicology Program, U.S. Department of Health and Human Services.
21. Sahu S.C., and Gray G.C. Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Letters 104 (1996) 193-196
22. Samson H.H., Waterman D.L., and Woods S.C. Effect of acute maternal ethanol exposure upon foetal development in the rat. Physiological Psychology 7 (1979) 311-315
23. Schimmer O., Hafele F., and Kruger A. The mutagenic potencies of plant extracts containing quercetin in Salmonella typhimurium TA98 and TA100. Mutation Research 206 (1988) 201-208
24. Shao Z., Vanden Hoek T., Xie J., Wojcik K., Chan K., Li C., Hamann K., Qin Y., Schumacker P., Becker L., and Yuan C. Grape seed proanthocyanidins induce pro-oxidant toxicity in cardiomyocytes. Cardiovascular Toxicology 3 (2003) 331-339
25. Syme M., Paxton J., and Keelan J. Drug transfer and metabolism by the human placenta. Clinical Pharmacokinetics 43 (2004) 487-514
26. Upton R. Hawthorn Berry (Crataegus spp.) Analytical, Quality Control and Therapeutic Monograph (1999), American Herbal Pharmacopocia, Santa Cruz, CA
27. Upton R. Hawthorn Leaf with Flower (Crataegus spp.) Analytical, Quality Control, and Therapeutic Monograph (1999), American Herbal Pharmacopocia, Santa Cruz, CA
28. Willhite C. Teratogenic potential of quercetin in the rat. Food & Chemical Toxicology 20 (1982) 75-79
29. Zuo Z., Zhang L., Zhou L., Chang Q., and Chow M. Intestinal absorption of hawthorn flavonoids-in vitro, in situ and in vivo correlations. Life Science 79 (2006) 2455-2462